Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
2 | Current Molecular Pharmacology | journal | 0.996 Q2 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | 28.00 | |
3 | Current Cancer Drug Targets | journal | 0.951 Q3 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | 44.49 | |
4 | Current Gene Therapy | journal | 0.951 Q2 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | 41.06 | |
5 | Current Genomics | journal | 0.922 Q3 | 77 | 47 | 153 | 5193 | 358 | 132 | 2.10 | 110.49 | 35.91 | |
6 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
7 | Current Diabetes Reviews | journal | 0.879 Q3 | 68 | 51 | 146 | 4391 | 353 | 133 | 1.90 | 86.10 | 47.37 | |
8 | Current Protein and Peptide Science | journal | 0.858 Q2 | 96 | 124 | 246 | 11582 | 625 | 209 | 2.27 | 93.40 | 42.57 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.760 Q3 | 52 | 27 | 83 | 3115 | 216 | 78 | 2.43 | 115.37 | 41.11 | |
10 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q3 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | 43.09 | |
11 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | 48.82 | |
12 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.513 Q3 | 45 | 28 | 71 | 1457 | 91 | 64 | 1.13 | 52.04 | 38.68 | |
13 | Current Aging Science | journal | 0.441 Q4 | 42 | 33 | 96 | 2138 | 165 | 87 | 1.53 | 64.79 | 42.16 | |
14 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.423 Q4 | 39 | 28 | 79 | 1570 | 121 | 64 | 1.30 | 56.07 | 48.96 | |
15 | Current Organic Synthesis | journal | 0.417 Q3 | 55 | 98 | 200 | 7339 | 346 | 188 | 1.48 | 74.89 | 37.90 | |
16 | Infectious Disorders - Drug Targets | journal | 0.323 Q4 | 61 | 28 | 88 | 886 | 82 | 76 | 0.95 | 31.64 | 40.19 | |
17 | Recent Patents on Biotechnology | journal | 0.317 Q3 | 42 | 18 | 77 | 1309 | 77 | 68 | 0.64 | 72.72 | 55.00 | |
18 | Drug Metabolism Letters | journal | 0.314 Q3 | 31 | 19 | 72 | 820 | 60 | 65 | 0.78 | 43.16 | 33.82 | |
19 | Current Nanoscience | journal | 0.292 Q3 | 52 | 75 | 346 | 3601 | 381 | 322 | 1.21 | 48.01 | 33.03 | |
20 | Open Medicinal Chemistry Journal | journal | 0.281 Q4 | 23 | 15 | 11 | 649 | 10 | 11 | 0.71 | 43.27 | 43.28 | |
21 | Current Computer-Aided Drug Design | journal | 0.259 Q4 | 32 | 33 | 116 | 1263 | 99 | 100 | 0.74 | 38.27 | 35.48 | |
22 | Current Bioinformatics | journal | 0.251 Q4 | 38 | 51 | 222 | 2433 | 135 | 202 | 0.52 | 47.71 | 30.00 | |
23 | Letters in Drug Design and Discovery | journal | 0.247 Q4 | 37 | 149 | 371 | 5398 | 362 | 368 | 0.89 | 36.23 | 43.22 | |
24 | Current Pharmaceutical Analysis | journal | 0.224 Q4 | 27 | 70 | 143 | 1998 | 106 | 134 | 0.75 | 28.54 | 49.42 | |
25 | Current Enzyme Inhibition | journal | 0.197 Q4 | 19 | 21 | 56 | 1234 | 36 | 50 | 0.65 | 58.76 | 32.14 | |
26 | Current Proteomics | journal | 0.195 Q4 | 27 | 34 | 106 | 1795 | 63 | 98 | 0.56 | 52.79 | 54.78 | |
27 | Letters in Organic Chemistry | journal | 0.190 Q4 | 33 | 110 | 344 | 3794 | 198 | 341 | 0.53 | 34.49 | 37.78 | |
28 | Current Chemical Biology | journal | 0.178 Q4 | 26 | 16 | 45 | 917 | 30 | 43 | 0.53 | 57.31 | 38.00 | |
29 | Open Biotechnology Journal | journal | 0.162 Q4 | 18 | 11 | 103 | 378 | 41 | 99 | 0.41 | 34.36 | 36.11 | |
30 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 11 | 81 | 742 | 13 | 68 | 0.06 | 67.45 | 29.79 | |
31 | Journal of Biology and Today's World (discontinued) | journal | 0.139 Q4 | 8 | 39 | 37 | 1225 | 14 | 37 | 0.38 | 31.41 | 49.11 | |
32 | Current Signal Transduction Therapy | journal | 0.129 Q4 | 22 | 9 | 68 | 533 | 13 | 64 | 0.22 | 59.22 | 42.86 | |
33 | Current Pharmacogenomics and Personalized Medicine | journal | 0.123 Q4 | 20 | 16 | 56 | 1195 | 7 | 52 | 0.05 | 74.69 | 58.33 | |
34 | Open Biomarkers Journal | journal | 0.123 Q4 | 7 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
35 | Current Angiogenesis | journal | 0.106 Q4 | 6 | 0 | 30 | 0 | 3 | 25 | 0.17 | 0.00 | 0.00 | |
36 | International Journal of Engineering and Technology(UAE) (discontinued) | journal | 0.102 Q4 | 37 | 28 | 25 | 582 | 2 | 25 | 0.08 | 20.79 | 36.73 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®